Big Money Are Betting On Nanoviricides Inc (NYSEMKT:NNVC), Sentiment at 2

“Big money” Positions

In Q2 2018 Nanoviricides Inc (NYSEMKT:NNVC) big money sentiment increased to 2, according to Securities and Exchange Commission filings. So its up 1.00, from 2018Q1’s 1. 12 investment managers started new and increased equity positions, while 6 sold and reduced positions in Nanoviricides Inc so the sentiment has improved. Funds own 3.64 million shares, up from 3.49 million shares in 2018Q1. Funds holding Nanoviricides Inc in top 10 changed to 0 from 0 for the same number . In total 2 funds closed positions, 4 reduced and 7 increased. Also 5 funds bought new Nanoviricides Inc stakes.

Most Nanoviricides Inc Investors

As of Q2 2018 Pioneer Trust Bank N A Or has 0.02% invested in Nanoviricides Inc. Nanoviricides Inc’s shareholder Wharton Business Group Llc owns 363,513 shares as of Q2 2018. In addition, Bank Of America Corp De reported 15,817 shares in Nanoviricides Inc equivalent to 0% of its portfolio. Bank Of New York Mellon Corp revealed 39,349 shares position in Nanoviricides Inc. The Ohio-based fund Bartlett & Co. Llc holds 40,714 shares or 0% of their portfolio.

NanoViricides, Inc., a nano-biopharmaceutical company, discovers, develops, and commercializes therapeutics for the treatment of viral infections.The firm is worth $25.50 million. The firm is developing anti-influenza drug candidates at pre-clinical and advanced pre-clinical stage, which include two FluCide drugs comprising NV-INF-2, an oral anti-influenza drug and NV-INF-1, an injectable anti-influenza drug for novel strain of H7N9, Bird Flu H5N1, and other Highly Pathogenic Influenzas; and HIVCide, an anti-human immunodeficiency virus drug candidate that could enable a functional cure for HIV/AIDS.Last it reported negative earnings. It is also developing HerpeCide, a skin cream or gel formulation for the treatment of oral and genital herpes lesions; anti-viral eye drops against external eye viral infections; and other research programs against Rabies virus, Ebola, and Marburg viruses.

Ticker’s shares touched $0.3675 during the last trading session after 5.00% change.Currently NanoViricides, Inc. is downtrending after 72.63% change in last December 8, 2017. NNVC has 37,778 shares volume. NNVC underperformed by 88.25% the S&P500.

Virtu Ltd Liability Company holds 0% of its capital in NanoViricides, Inc. (NYSEAMERICAN:NNVC) for 12,493 shs. Sequoia Finance Advisors Limited Liability Company has invested 0% of its capital in NanoViricides, Inc. (NYSEAMERICAN:NNVC). Jpmorgan Chase & has invested 0% in NanoViricides, Inc. (NYSEAMERICAN:NNVC). North Star Investment Mngmt has 6,000 shs. Sandy Spring Bank owns 4,154 shs for 0% of their capital. Raymond James Services Advsr invested 0% in NanoViricides, Inc. (NYSEAMERICAN:NNVC). Fayez Sarofim & Co, Texas-based fund reported 28,572 shs. Renaissance Technologies Lc holds 531,500 shs or 0% of its capital. Geode Management Ltd reported 175,983 shs stake. Rathbone Brothers Plc has 0% invested in NanoViricides, Inc. (NYSEAMERICAN:NNVC). Royal Bank Of Canada holds 0% or 700 shs. Hightower Advsr Limited Liability Company holds 0% or 21,429 shs. Bartlett And Ltd Llc has 40,714 shs. Deutsche Bank Ag invested 0% in NanoViricides, Inc. (NYSEAMERICAN:NNVC). Cwm Limited reported 0% of its capital in NanoViricides, Inc. (NYSEAMERICAN:NNVC).

For more NanoViricides, Inc. (NYSEAMERICAN:NNVC) news published briefly go to:,,, or The titles are as follows: “Itaú Unibanco Holding SA: Announcement to the Market – BRGAAP – Result for the 3rd quarter of 2018 – The Wall Street Transcript” published on October 29, 2018, “Yum China Holdings Inc.: Yum China 3Q 2018 Earnings Conference Call Transcript – The Wall Street Transcript” on October 31, 2018, “NanoViricides Provides Update on Recent Events – PR Newswire” with a publish date: July 12, 2018, “Main Street Capital Corporation: Main Street Announces First Quarter 2019 Regular Monthly Dividends – The Wall Street Transcript” and the last “Safe Bulkers Inc.: Safe Bulkers, Inc. Sets Date for Third Quarter 2018 Results, Conference Call and Webcast – The Wall Street Transcript” with publication date: October 31, 2018.

NanoViricides, Inc. (NYSEAMERICAN:NNVC) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.